Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

This study has been completed.
Sponsor:
Information provided by:
DynPort Vaccine Company LLC, A CSC Company
ClinicalTrials.gov Identifier:
NCT00057525
First received: April 3, 2003
Last updated: June 29, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Primary Completion Date: April 2004 (Final data collection date for primary outcome measure)
No publications provided by DynPort Vaccine Company LLC, A CSC Company

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):